Global Targeted DNA RNA Sequencing Market was valued at USD 0.6 Billion in 2022 and is projected to reach USD 1.2 Billion by 2030, growing at a CAGR of 9.2% from 2024 to 2030.
The Targeted DNA RNA Sequencing market is witnessing significant growth, driven by advancements in genomic technologies and the increasing demand for personalized medicine. This niche sector of next-generation sequencing (NGS) is being propelled by the need for precise and cost-effective genetic analysis. Unlike traditional sequencing methods, targeted sequencing focuses on specific regions of the genome, making it faster and more efficient, offering valuable insights into diseases like cancer, genetic disorders, and infections.
In recent years, the adoption of targeted sequencing has been fueled by its ability to deliver high accuracy and resolution while reducing the overall costs. Researchers and healthcare providers prefer these solutions for their efficiency in generating high-quality data for diagnostic purposes. Moreover, the technology’s ability to provide in-depth analysis at the transcriptomic level has also expanded its use in RNA sequencing, where it helps detect gene expression and regulatory variations that are pivotal in understanding diseases at the molecular level.
Among the driving factors for market growth is the rising prevalence of chronic diseases globally. With healthcare institutions increasingly turning to genomic solutions for more accurate diagnoses and treatment plans, targeted DNA and RNA sequencing offers critical insights that aid in precision medicine. Furthermore, the growing availability of user-friendly sequencing kits and platforms that reduce barriers to entry is further accelerating adoption in both clinical and research settings.
North America continues to lead the market in terms of revenue generation, largely due to robust healthcare infrastructure, funding for genomic research, and the early adoption of NGS technologies. However, the Asia-Pacific region is expected to witness the highest growth rate, fueled by increased investments in healthcare infrastructure, research, and adoption of new genomic technologies.
Looking forward, the targeted DNA RNA sequencing market is expected to grow steadily, with advancements in AI and machine learning enhancing sequencing data analysis. As new technologies emerge, the cost of sequencing is expected to decrease, making this revolutionary tool more accessible to a broader range of institutions and researchers.
Â
Get an In-Depth Research Analysis of the Global Targeted DNA RNA Sequencing Market Size And Forecast [2025-2032]
Illumina
Inc
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific
Inc
DNASTAR Inc
QIAGEN
BGI
Perkin Elmer
Inc
Pacific Biosciences of California
Inc
Bio-Rad Laboratories
Inc
Integrated DNA Technologies
Inc
RainDance Technologies
Inc
PierianDx
Genomatix GmbH
Macrogen
Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Targeted DNA RNA Sequencing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Targeted DNA RNA Sequencing Market
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
Based on Types the Market is categorized into Below types that held the largest Targeted DNA RNA Sequencing market share In 2023.
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Global, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Targeted DNA RNA Sequencing Market Research Analysis
1. Introduction of the Global Targeted DNA RNA Sequencing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Targeted DNA RNA Sequencing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Targeted DNA RNA Sequencing Market, By Type
6. Global Targeted DNA RNA Sequencing Market, By Application
7. Global Targeted DNA RNA Sequencing Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Targeted DNA RNA Sequencing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/